Lakefront Biotherapeutics NV (GLPG) Form 6-K — Aug 25, 2026
Lakefront Biotherapeutics received a Belgian transparency notification on August 19, 2026, indicating that Bank of America Corporation, as controlling entity, crossed above the 10% voting-rights threshold on August 18, 2026, following the acquisition of Lakefront voting rights and equivalent financial instruments. As of the notification, the Bank of America group held 1,419,144 direct voting rights (2.15%) plus 5,243,453 equivalent financial instruments such as swaps and rights to use or recall shares (7.96%), for a combined 6,662,597 voting rights, or 10.11% of Lakefront's 65,897,071 shares outstanding.
Key figures
- Shares Outstanding
- 65897071
- Total Percent
- 10.11%
- Notification Date
- August 19, 2026
- Threshold Crossed
- 10%
- Direct Voting Rights
- 1419144
- Threshold Crossed Date
- August 18, 2026
- Largest Single Instrument
- BofA Securities, Inc. right to use covering 4,757,362 underlying shares (7.22%)
- Direct Voting Rights Percent
- 2.15%
- Total Position Voting Rights
- 6662597
- Equivalent Instruments Percent
- 7.96%
- Equivalent Financial Instruments
- 5243453
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.